EUVIMEDEUVIMED entdecken
Crossref

Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

Gaetano Pacinella, Alessandro Del Cuore, Maria Grazia Basso, Alessandra Casuccio, Daniela Colomba, Giuseppe Miceli, Vittoriano Della Corte, Mario Daidone, Tiziana Di Chiara, Irene Simonetta, Rosaria Pecoraro, Luisa Agnello und 7 weitere

Aging · 11.02.2026 · 18 (1) · 893-907

DOI: 10.18632/aging.206397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, online erschienen am 23.07.2026. Verfasst von Gaetano Pacinella und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Promoting Health, Maternal-Infant, Excellence, and Internal and Specialised Medicine (PROMISE) G. D’Alessandro, University of Palermo, …. Hauptthemen laut MEDLINE: Lipocalin-2, Cognitive Dysfunction, Fatty Liver, Neuroinflammatory Diseases. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognised as a systemic condition associated with cardiometabolic and neurovascular alterations. Lipocalin-2 (LCN2), a marker of adipo-neuroinflammation, may represent a link between metabolic dysfunction, vascular impairment, and cognitive decline. MATERIALS AND METHODS: In this cross-sectional study, we enrolled a group of 40 patients with a recent diagnosis of MASLD and a control group of 40 patients with no history of anamnestic or active liver disease. We evaluated serum LCN2 levels, endothelial function assessed by reactive hyperemia index (RHI), myocardial mechano-energetic efficiency (MMEE), and cognitive performance using the Mini-Mental State Examination (MMSE). Multivariable analyses were adjusted for age, BMI, and diabetes mellitus. RESULTS: Compared with controls, patients with MASLD showed higher LCN2 levels, lower RHI and MMEE values, and lower MMSE scores. MASLD was independently associated with lower RHI, lower MMSE, and higher LCN2 levels in multivariable models. However, additional partial correlation analyses adjusting for major cardiometabolic confounders did not confirm independent associations between LCN2 and vascular or cognitive parameters. CONCLUSIONS: MASLD is associated with endothelial dysfunction, early cognitive changes, and increased LCN2 levels. However, these relationships appear to be largely influenced by the underlying cardiometabolic profile. LCN2 should be interpreted primarily as a marker of systemic metabolic and inflammatory burden rather than as a causal mediator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipocalin-2Cognitive DysfunctionFatty LiverNeuroinflammatory DiseasesCardiovascular DiseasesHumansFemaleMaleCross-Sectional StudiesBiomarkersMiddle AgedAgedMetabolic Diseases

Stichwörter der Autor:innen

cardiovascular riskcognitive impairmentendothelial dysfunctionlipocalin-2metabolic dysfunction

Substanzen

Lipocalin-2BiomarkersLCN2 protein, human

Autor:innen und Institutionen

  • Department of Promoting Health, Maternal-Infant, Excellence, and Internal and Specialised Medicine (PROMISE) G. D’Alessandro, University of Palermo, Palermo 90127, Italy.
  • Internal Medicine and Stroke Care Ward, Policlinico “P. Giaccone”, Palermo 90127, Italy.
  • Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences, and Advanced Diagnostics, University of Palermo, Palermo 90127, Italy.
  • Section of Gastroenterology and Hepatology, University of Palermo, Palermo 90127, Italy.

Zitieren

APA

Pacinella, G., Cuore, A. D., Basso, M. G., Casuccio, A., Colomba, D., Miceli, G., Corte, V. D., Daidone, M., Chiara, T. D., Simonetta, I., Pecoraro, R., Agnello, L., Ciaccio, M., Petta, S., Craxì, A., Pennisi, G., Cammà, C., Raimondo, D. D., & Tuttolomondo, A. (2026). Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). Aging, 18(1), 893-907. https://doi.org/10.18632/aging.206397

Vancouver

Pacinella G, Cuore AD, Basso MG, Casuccio A, Colomba D, Miceli G, et al. Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). Aging. 2026;18(1):893-907. doi:10.18632/aging.206397

BibTeX
@article{Pacinella2026,
  author = {Pacinella, Gaetano and Cuore, Alessandro Del and Basso, Maria Grazia and Casuccio, Alessandra and Colomba, Daniela and Miceli, Giuseppe and Corte, Vittoriano Della and Daidone, Mario and Chiara, Tiziana Di and Simonetta, Irene and Pecoraro, Rosaria and Agnello, Luisa and Ciaccio, Marcello and Petta, Salvatore and Craxì, Antonio and Pennisi, Grazia and Cammà, Calogero and Raimondo, Domenico Di and Tuttolomondo, Antonino},
  title = {Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)},
  journal = {Aging},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {893--907},
  doi = {10.18632/aging.206397}
}
Kostenlos starten →